Month: March 2013

Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy

AIDS: 12 April 2002 – Volume 16 – Issue 6 – pp 934-937 Research Letters Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy Collazos, Julio; Martinez, Eduardo; Mayo, José; Ibarra, Sofia Free Access Article Outline Author Information Section of Infectious Diseases, Hospital de Galdakao, Vizcaya, Spain. Received: 3 August 2001; revised: 16 November …

Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy Read More »

New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation)

All of the presentations in this section were great. The one on new drugs is contained in the last set of slides (blue slides at 1:22:46) https://webcasts.retroconference.org/console/player/19437?mediaType=podiumVideo For individual reports on each drug (Thanks to Natap.org): NEW HIV DRUGS at CROI Dolutegravir Treatment Response and Safety by Key Subgroups in Treatment Naive HIV Infected Individuals – (03/16/13) Dolutegravir (DTG) …

New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation) Read More »

“Functional Cure” of HIV Claimed for Baby Treated 30 Hours After Birth

NATAP https://natap.org/_______________________________________________ “Functional Cure” of HIV Claimed for Baby Treated 30 Hours After Birth 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013, Atlanta Mark Mascolini An HIV-infected US infant treated from 30 hour after birth had no detectable viral load, no detectable HIV DNA in blood cells, and no HIV-specific antibodies at 26 months …

“Functional Cure” of HIV Claimed for Baby Treated 30 Hours After Birth Read More »

Scroll to Top